VST Vistra | $91.47 +1.4% | 5/7/2024 | Upgraded by | Guggenheim | Analyst S. Pourreza | Strong-Buy | | Low | View details for Guggenheim rating of Vistra (NYSE:VST) on 5/7/2024 |
FOLD Amicus Therapeutics | $9.33 +3.2% | 5/14/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $13.00 | Low | View details for Guggenheim rating of Amicus Therapeutics (NASDAQ:FOLD) on 5/14/2024 |
RAPT RAPT Therapeutics | $4.00 -9.1% | 5/10/2024 | Downgraded by | Guggenheim | Analyst Y. Suneja | Buy -> Neutral | | Low | View details for Guggenheim rating of RAPT Therapeutics (NASDAQ:RAPT) on 5/10/2024 |
ACCD Accolade | $7.36 +2.1% | 5/8/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $17.00 -> $13.00 | Low | View details for Guggenheim rating of Accolade (NASDAQ:ACCD) on 5/8/2024 |
APTV Aptiv | $82.84 +0.1% | 5/8/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $92.00 -> $94.00 | Low | View details for Guggenheim rating of Aptiv (NYSE:APTV) on 5/8/2024 |
CFLT Confluent | $30.67 +2.4% | 5/8/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $35.00 -> $37.00 | Low | View details for Guggenheim rating of Confluent (NASDAQ:CFLT) on 5/8/2024 |
|
ETSY Etsy | $63.57 +1.7% | 5/2/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $95.00 -> $80.00 | Low | View details for Guggenheim rating of Etsy (NASDAQ:ETSY) on 5/2/2024 |
FSLR First Solar | $186.97 -1.4% | 5/2/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $359.00 -> $356.00 | Low | View details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 5/2/2024 |
MCD McDonald's | $270.66 -0.2% | 5/2/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $325.00 -> $315.00 | Low | View details for Guggenheim rating of McDonald’s (NYSE:MCD) on 5/2/2024 |
NBIX Neurocrine Biosciences | $138.48 +1.7% | 5/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $164.00 -> $170.00 | Low | View details for Guggenheim rating of Neurocrine Biosciences (NASDAQ:NBIX) on 5/2/2024 |
DCPH Deciphera Pharmaceuticals | $25.44 +0.1% | 4/30/2024 | Reiterated by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Deciphera Pharmaceuticals (NASDAQ:DCPH) on 4/30/2024 |
DTIL Precision BioSciences | $11.62 +1.0% | 4/30/2024 | Initiated by | Guggenheim | - | Buy | $19.00 | Low | View details for Guggenheim rating of Precision BioSciences (NASDAQ:DTIL) on 4/30/2024 |
ABVX ABIVAX Société Anonyme | $13.82 -0.9% | 4/29/2024 | Initiated by | Guggenheim | - | Buy | $50.00 | Low | View details for Guggenheim rating of ABIVAX Société Anonyme (NASDAQ:ABVX) on 4/29/2024 |
ALT Altimmune | $7.82 +6.1% | 4/29/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Altimmune (NASDAQ:ALT) on 4/29/2024 |
META Meta Platforms | $471.85 +0.8% | 4/25/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $520.00 -> $500.00 | N/A | View details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 4/25/2024 |
SPOT Spotify Technology | $290.12 +0.1% | 4/24/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $290.00 -> $350.00 | Low | View details for Guggenheim rating of Spotify Technology (NYSE:SPOT) on 4/24/2024 |
MEDP Medpace | $398.52 +2.4% | 4/24/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $453.00 -> $464.00 | Low | View details for Guggenheim rating of Medpace (NASDAQ:MEDP) on 4/24/2024 |
ENPH Enphase Energy | $117.11 +5.7% | 4/24/2024 | Downgraded by | Guggenheim | - | Neutral -> Sell | $92.00 | Low | View details for Guggenheim rating of Enphase Energy (NASDAQ:ENPH) on 4/24/2024 |
ANIP ANI Pharmaceuticals | $66.21 -1.7% | 4/23/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $77.00 | Low | View details for Guggenheim rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 4/23/2024 |
IMCR Immunocore | $55.85 -2.0% | 4/23/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $92.00 | Low | View details for Guggenheim rating of Immunocore (NASDAQ:IMCR) on 4/23/2024 |
INFA Informatica | $29.64 +0.7% | 4/23/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $37.00 | Low | View details for Guggenheim rating of Informatica (NYSE:INFA) on 4/23/2024 |
TSLA Tesla | $177.55 +3.3% | 4/23/2024 | Reiterated by | Guggenheim | - | Sell -> Sell | $122.00 -> $122.00 | Low | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 4/23/2024 |
NXT Nextracker | $43.01 -0.1% | 4/23/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $73.00 -> $60.00 | Low | View details for Guggenheim rating of Nextracker (NASDAQ:NXT) on 4/23/2024 |
SBUX Starbucks | $75.63 -0.7% | 4/19/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $100.00 -> $91.00 | Low | View details for Guggenheim rating of Starbucks (NASDAQ:SBUX) on 4/19/2024 |
VRTX Vertex Pharmaceuticals | $428.59 -0.3% | 4/18/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $445.00 -> $450.00 | Low | View details for Guggenheim rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 4/18/2024 |
AN AutoNation | $170.57 +1.0% | 4/17/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $165.00 -> $169.00 | N/A | View details for Guggenheim rating of AutoNation (NYSE:AN) on 4/17/2024 |
APTV Aptiv | $82.84 +0.1% | 4/17/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $103.00 -> $92.00 | N/A | View details for Guggenheim rating of Aptiv (NYSE:APTV) on 4/17/2024 |
GNTX Gentex | $34.75 +0.1% | 4/17/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $40.00 -> $41.00 | N/A | View details for Guggenheim rating of Gentex (NASDAQ:GNTX) on 4/17/2024 |
LAD Lithia Motors | $274.95 +0.1% | 4/17/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $320.00 -> $297.00 | N/A | View details for Guggenheim rating of Lithia Motors (NYSE:LAD) on 4/17/2024 |
VC Visteon | $116.88 +1.6% | 4/17/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $136.00 -> $126.00 | N/A | View details for Guggenheim rating of Visteon (NASDAQ:VC) on 4/17/2024 |
GPI Group 1 Automotive | $322.62 +3.0% | 4/17/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $305.00 | Low | View details for Guggenheim rating of Group 1 Automotive (NYSE:GPI) on 4/17/2024 |
NFLX Netflix | $613.66 -0.5% | 4/16/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $600.00 -> $700.00 | Low | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 4/16/2024 |
NOW ServiceNow | $721.62 -1.2% | 4/15/2024 | Reiterated by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of ServiceNow (NYSE:NOW) on 4/15/2024 |
IMNM Immunome | $14.72 -5.7% | 4/15/2024 | Initiated by | Guggenheim | - | Buy | $35.00 | Low | View details for Guggenheim rating of Immunome (NASDAQ:IMNM) on 4/15/2024 |
ENGN enGene | $14.24 +0.1% | 4/15/2024 | Initiated by | Guggenheim | - | Buy | $34.00 | Low | View details for Guggenheim rating of enGene (NASDAQ:ENGN) on 4/15/2024 |
ALPN Alpine Immune Sciences | $64.94 0.0% | 4/9/2024 | Initiated by | Guggenheim | - | Buy | $55.00 | Low | View details for Guggenheim rating of Alpine Immune Sciences (NASDAQ:ALPN) on 4/9/2024 |
VERA Vera Therapeutics | $40.86 +0.3% | 4/5/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $56.00 | Low | View details for Guggenheim rating of Vera Therapeutics (NASDAQ:VERA) on 4/5/2024 |
WMG Warner Music Group | $32.15 -0.3% | 4/5/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $46.00 -> $45.00 | Low | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 4/5/2024 |
RCM R1 RCM | $12.22 +2.3% | 4/5/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $17.00 -> $15.00 | Low | View details for Guggenheim rating of R1 RCM (NASDAQ:RCM) on 4/5/2024 |
ARRY Array Technologies | $12.64 -0.2% | 4/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $20.00 -> $22.00 | N/A | View details for Guggenheim rating of Array Technologies (NASDAQ:ARRY) on 4/5/2024 |
HUGE BUY ALERT: Move Fast, Musk... (Ad) I recently traveled to Phoenix, Arizona...And based on what I saw out there, I'm prepared to put my reputation on the line.
Since 2018, my investment recommendations have averaged 115% per year.
But one investment I've just discovered could blow them all away. You won't believe what I saw in Phoenix. |
BROS Dutch Bros | $36.07 +2.5% | 4/5/2024 | Reiterated by | Guggenheim | - | Neutral -> Neutral | $30.00 | Low | View details for Guggenheim rating of Dutch Bros (NYSE:BROS) on 4/5/2024 |
ADCT ADC Therapeutics | $4.04 -3.6% | 4/5/2024 | Reiterated by | Guggenheim | - | Buy | | Low | View details for Guggenheim rating of ADC Therapeutics (NYSE:ADCT) on 4/5/2024 |
CVAC CureVac | $3.10 +4.4% | 4/5/2024 | Reiterated by | Guggenheim | - | Neutral | | Low | View details for Guggenheim rating of CureVac (NASDAQ:CVAC) on 4/5/2024 |
GH Guardant Health | $24.73 +3.0% | 4/5/2024 | Reiterated by | Guggenheim | - | Neutral | | Low | View details for Guggenheim rating of Guardant Health (NASDAQ:GH) on 4/5/2024 |
HD Home Depot | $340.50 -0.1% | 4/5/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $390.00 | Low | View details for Guggenheim rating of Home Depot (NYSE:HD) on 4/5/2024 |
IVVD Invivyd | $2.43 +2.5% | 4/5/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $9.00 | Low | View details for Guggenheim rating of Invivyd (NASDAQ:IVVD) on 4/5/2024 |
PRKS United Parks & Resorts | $54.08 +0.5% | 4/4/2024 | Initiated by | Guggenheim | - | Buy | $73.00 | Low | View details for Guggenheim rating of United Parks & Resorts (NYSE:PRKS) on 4/4/2024 |
DIS Walt Disney | $105.33 -0.5% | 4/3/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $125.00 -> $140.00 | Low | View details for Guggenheim rating of Walt Disney (NYSE:DIS) on 4/3/2024 |
EDR Endeavor Group | $26.54 +0.2% | 4/3/2024 | Reiterated by | Guggenheim | - | Buy -> Neutral | $36.00 -> $27.50 | Low | View details for Guggenheim rating of Endeavor Group (NYSE:EDR) on 4/3/2024 |
PVH PVH | $116.31 +2.4% | 4/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $120.00 -> $140.00 | Low | View details for Guggenheim rating of PVH (NYSE:PVH) on 4/2/2024 |
ADCT ADC Therapeutics | $4.04 -3.6% | 3/28/2024 | Initiated by | Guggenheim | - | Buy | $11.00 | Low | View details for Guggenheim rating of ADC Therapeutics (NYSE:ADCT) on 3/28/2024 |
VERA Vera Therapeutics | $40.86 +0.3% | 3/27/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $27.00 -> $56.00 | Low | View details for Guggenheim rating of Vera Therapeutics (NASDAQ:VERA) on 3/27/2024 |
TVTX Travere Therapeutics | $6.72 +6.0% | 3/27/2024 | Reiterated by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 3/27/2024 |
VYGR Voyager Therapeutics | $8.47 -0.1% | 3/26/2024 | Initiated by | Guggenheim | - | Buy | $22.00 | Low | View details for Guggenheim rating of Voyager Therapeutics (NASDAQ:VYGR) on 3/26/2024 |
VALN Valneva | $8.13 +6.8% | 3/22/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $18.00 -> $17.00 | Low | View details for Guggenheim rating of Valneva (NASDAQ:VALN) on 3/22/2024 |
ABBV AbbVie | $161.59 +0.2% | 3/22/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $188.00 -> $190.00 | Low | View details for Guggenheim rating of AbbVie (NYSE:ABBV) on 3/22/2024 |
LULU Lululemon Athletica | $352.35 +1.5% | 3/22/2024 | Target Lowered by | Guggenheim | - | Buy | $550.00 -> $525.00 | Low | View details for Guggenheim rating of Lululemon Athletica (NASDAQ:LULU) on 3/22/2024 |
TSQ Townsquare Media | $11.57 +0.2% | 3/20/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $12.00 -> $12.50 | Low | View details for Guggenheim rating of Townsquare Media (NYSE:TSQ) on 3/20/2024 |
TIXT TELUS International (Cda) | $6.42 -0.8% | 3/19/2024 | Initiated by | Guggenheim | - | Neutral | $9.00 | Low | View details for Guggenheim rating of TELUS International (Cda) (NYSE:TIXT) on 3/19/2024 |
TASK TaskUs | $14.76 +4.1% | 3/19/2024 | Initiated by | Guggenheim | - | Neutral | $13.00 | Low | View details for Guggenheim rating of TaskUs (NASDAQ:TASK) on 3/19/2024 |
DXC DXC Technology | $19.80 +1.4% | 3/19/2024 | Initiated by | Guggenheim | - | Neutral | $22.00 | Low | View details for Guggenheim rating of DXC Technology (NYSE:DXC) on 3/19/2024 |
TTEC TTEC | $7.35 -1.5% | 3/19/2024 | Initiated by | Guggenheim | - | Sell | $8.00 | Low | View details for Guggenheim rating of TTEC (NASDAQ:TTEC) on 3/19/2024 |
PRFT Perficient | $73.44 0.0% | 3/19/2024 | Initiated by | Guggenheim | - | Neutral | $65.00 | Low | View details for Guggenheim rating of Perficient (NASDAQ:PRFT) on 3/19/2024 |
GLOB Globant | $174.45 -0.4% | 3/19/2024 | Initiated by | Guggenheim | - | Buy | $250.00 | Low | View details for Guggenheim rating of Globant (NYSE:GLOB) on 3/19/2024 |
DAVA Endava | $29.98 -1.6% | 3/19/2024 | Initiated by | Guggenheim | - | Buy | $60.00 | Low | View details for Guggenheim rating of Endava (NYSE:DAVA) on 3/19/2024 |
DRI Darden Restaurants | $148.94 -0.1% | 3/19/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $180.00 -> $185.00 | Low | View details for Guggenheim rating of Darden Restaurants (NYSE:DRI) on 3/19/2024 |
GNTX Gentex | $34.75 +0.1% | 3/19/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $38.00 -> $40.00 | Low | View details for Guggenheim rating of Gentex (NASDAQ:GNTX) on 3/19/2024 |
KR Kroger | $55.28 +0.1% | 3/19/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $60.00 -> $61.00 | Low | View details for Guggenheim rating of Kroger (NYSE:KR) on 3/19/2024 |
ACN Accenture | $306.95 -0.1% | 3/19/2024 | Initiated by | Guggenheim | - | Buy | $425.00 | Low | View details for Guggenheim rating of Accenture (NYSE:ACN) on 3/19/2024 |
INFY Infosys | $16.95 +0.2% | 3/19/2024 | Initiated by | Guggenheim | - | Neutral | $20.00 | Low | View details for Guggenheim rating of Infosys (NYSE:INFY) on 3/19/2024 |
CTSH Cognizant Technology Solutions | $67.78 -0.1% | 3/19/2024 | Initiated by | Guggenheim | - | Neutral | $80.00 | Low | View details for Guggenheim rating of Cognizant Technology Solutions (NASDAQ:CTSH) on 3/19/2024 |
EPAM EPAM Systems | $187.05 -1.9% | 3/19/2024 | Initiated by | Guggenheim | - | Buy | $350.00 | Low | View details for Guggenheim rating of EPAM Systems (NYSE:EPAM) on 3/19/2024 |
IMRX Immuneering | $1.60 +0.6% | 3/14/2024 | Reiterated by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Immuneering (NASDAQ:IMRX) on 3/14/2024 |
WW WW International | $2.08 +1.0% | 3/18/2024 | Reiterated by | Guggenheim | - | Buy -> Buy | $12.00 | Low | View details for Guggenheim rating of WW International (NASDAQ:WW) on 3/18/2024 |
SNOW Snowflake | $160.95 +0.7% | 3/15/2024 | Upgraded by | Guggenheim | - | Sell -> Neutral | | Low | View details for Guggenheim rating of Snowflake (NYSE:SNOW) on 3/15/2024 |
SIRI Sirius XM | $3.17 +1.0% | 3/14/2024 | Initiated by | Guggenheim | - | Neutral | $4.00 | Low | View details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 3/14/2024 |
SPRB Spruce Biosciences | $0.82 +2.5% | 3/14/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Spruce Biosciences (NASDAQ:SPRB) on 3/14/2024 |
FL Foot Locker | $22.91 +0.7% | 3/7/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $35.00 -> $30.00 | Low | View details for Guggenheim rating of Foot Locker (NYSE:FL) on 3/7/2024 |
EOSE Eos Energy Enterprises | $0.82 +13.9% | 3/7/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $10.00 -> $4.00 | Low | View details for Guggenheim rating of Eos Energy Enterprises (NASDAQ:EOSE) on 3/7/2024 |
YUM Yum! Brands | $137.49 +0.8% | 3/7/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $145.00 -> $155.00 | Low | View details for Guggenheim rating of Yum! Brands (NYSE:YUM) on 3/7/2024 |
BASE Couchbase | $25.98 -0.4% | 3/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $27.00 -> $32.00 | Low | View details for Guggenheim rating of Couchbase (NASDAQ:BASE) on 3/6/2024 |
CRWD CrowdStrike | $329.55 +3.2% | 3/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $358.00 -> $424.00 | N/A | View details for Guggenheim rating of CrowdStrike (NASDAQ:CRWD) on 3/6/2024 |
ROST Ross Stores | $132.86 -0.6% | 3/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $140.00 -> $165.00 | Low | View details for Guggenheim rating of Ross Stores (NASDAQ:ROST) on 3/6/2024 |
TGT Target | $158.96 -1.2% | 3/6/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $160.00 -> $190.00 | Low | View details for Guggenheim rating of Target (NYSE:TGT) on 3/6/2024 |
ANIP ANI Pharmaceuticals | $66.21 -1.7% | 3/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $70.00 -> $77.00 | Low | View details for Guggenheim rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 3/5/2024 |
PRME Prime Medicine | $6.66 +3.7% | 3/5/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $24.00 -> $20.00 | Low | View details for Guggenheim rating of Prime Medicine (NYSE:PRME) on 3/5/2024 |
APGE Apogee Therapeutics | $53.99 +2.4% | 3/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $44.00 -> $91.00 | Low | View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 3/5/2024 |
DLTR Dollar Tree | $118.88 -1.1% | 3/5/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $155.00 -> $170.00 | Low | View details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 3/5/2024 |
IHRT iHeartMedia | $1.26 +1.6% | 3/4/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $6.00 -> $5.00 | Low | View details for Guggenheim rating of iHeartMedia (NASDAQ:IHRT) on 3/4/2024 |
MDB MongoDB | $359.27 +0.0% | 3/4/2024 | Target Raised by | Guggenheim | - | Sell -> Sell | $250.00 -> $272.00 | Low | View details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 3/4/2024 |
My system predicted the BA collapse – now it’s issuing an AI warning (Ad) Even after several plane crashes and equipment malfunctions... a congressional hearing... and the worst PR firestorm in recent memory...
The FTC's commission chair Lina Khan still deems Boeing (BA), "too big to fail" Click to see why a similar situation is currently brewing in the AI market... |
D Dominion Energy | $52.84 -0.4% | 3/4/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $57.00 -> $52.00 | Low | View details for Guggenheim rating of Dominion Energy (NYSE:D) on 3/4/2024 |
GSK GSK | $45.66 +1.1% | 3/4/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | | Low | View details for Guggenheim rating of GSK (NYSE:GSK) on 3/4/2024 |
AMRC Ameresco | $29.98 +5.0% | 2/29/2024 | Reiterated by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Ameresco (NYSE:AMRC) on 2/29/2024 |
MRSN Mersana Therapeutics | $2.61 -0.4% | 2/29/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $7.00 | Low | View details for Guggenheim rating of Mersana Therapeutics (NASDAQ:MRSN) on 2/29/2024 |
NUVL Nuvalent | $68.02 +2.9% | 2/28/2024 | Initiated by | Guggenheim | - | Buy | $99.00 | Low | View details for Guggenheim rating of Nuvalent (NASDAQ:NUVL) on 2/28/2024 |
INSM Insmed | $25.45 -1.5% | 2/27/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $52.00 -> $54.00 | Low | View details for Guggenheim rating of Insmed (NASDAQ:INSM) on 2/27/2024 |
KRYS Krystal Biotech | $159.47 +3.0% | 2/27/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $130.00 -> $175.00 | Low | View details for Guggenheim rating of Krystal Biotech (NASDAQ:KRYS) on 2/27/2024 |
WDAY Workday | $246.88 -0.1% | 2/27/2024 | Reiterated by | Guggenheim | - | Sell -> Sell | $190.00 | Low | View details for Guggenheim rating of Workday (NASDAQ:WDAY) on 2/27/2024 |
BGNE BeiGene | $160.70 -0.9% | 2/27/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $350.00 -> $345.00 | Low | View details for Guggenheim rating of BeiGene (NASDAQ:BGNE) on 2/27/2024 |
CLDX Celldex Therapeutics | $39.47 -1.6% | 2/27/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $72.00 -> $90.00 | Low | View details for Guggenheim rating of Celldex Therapeutics (NASDAQ:CLDX) on 2/27/2024 |
HIMS Hims & Hers Health | $13.74 +6.6% | 2/27/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $15.00 -> $17.00 | Low | View details for Guggenheim rating of Hims & Hers Health (NYSE:HIMS) on 2/27/2024 |
FND Floor & Decor | $123.55 +0.8% | 2/27/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $115.00 -> $130.00 | Low | View details for Guggenheim rating of Floor & Decor (NYSE:FND) on 2/27/2024 |
PFE Pfizer | $28.35 -0.3% | 2/23/2024 | Initiated by | Guggenheim | - | Buy | $36.00 | Low | View details for Guggenheim rating of Pfizer (NYSE:PFE) on 2/23/2024 |
AXSM Axsome Therapeutics | $77.40 +2.3% | 2/21/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $110.00 -> $125.00 | Low | View details for Guggenheim rating of Axsome Therapeutics (NASDAQ:AXSM) on 2/21/2024 |
CNP CenterPoint Energy | $29.68 +0.1% | 2/21/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $33.00 -> $32.00 | Low | View details for Guggenheim rating of CenterPoint Energy (NYSE:CNP) on 2/21/2024 |
CRWD CrowdStrike | $329.55 +3.2% | 2/21/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $274.00 -> $358.00 | Low | View details for Guggenheim rating of CrowdStrike (NASDAQ:CRWD) on 2/21/2024 |
HD Home Depot | $340.50 -0.1% | 2/21/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $370.00 -> $390.00 | Low | View details for Guggenheim rating of Home Depot (NYSE:HD) on 2/21/2024 |
S SentinelOne | $21.59 +0.1% | 2/21/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $26.00 -> $32.00 | Low | View details for Guggenheim rating of SentinelOne (NYSE:S) on 2/21/2024 |
SPRB Spruce Biosciences | $0.82 +2.5% | 2/21/2024 | Initiated by | Guggenheim | - | Buy | $10.00 | Low | View details for Guggenheim rating of Spruce Biosciences (NASDAQ:SPRB) on 2/21/2024 |
BTSG BrightSpring Health Services | $11.30 +0.5% | 2/20/2024 | Initiated by | Guggenheim | - | Buy | $15.00 | Low | View details for Guggenheim rating of BrightSpring Health Services (NASDAQ:BTSG) on 2/20/2024 |
SPWR SunPower | $4.39 +59.6% | 2/16/2024 | Downgraded by | Guggenheim | - | Neutral -> Sell | | Low | View details for Guggenheim rating of SunPower (NASDAQ:SPWR) on 2/16/2024 |
CRL Charles River Laboratories International | $232.82 +1.9% | 2/15/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Charles River Laboratories International (NYSE:CRL) on 2/15/2024 |
IQV IQVIA | $231.14 +0.9% | 2/15/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of IQVIA (NYSE:IQV) on 2/15/2024 |
GNRC Generac | $143.08 +2.1% | 2/15/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Generac (NYSE:GNRC) on 2/15/2024 |
QSR Restaurant Brands International | $71.75 -0.5% | 2/14/2024 | Target Raised by | Guggenheim | - | Neutral | $70.00 -> $74.00 | Low | View details for Guggenheim rating of Restaurant Brands International (NYSE:QSR) on 2/14/2024 |
NXT Nextracker | $43.01 -0.1% | 2/8/2024 | Initiated by | Guggenheim | - | Buy | $73.00 | Low | View details for Guggenheim rating of Nextracker (NASDAQ:NXT) on 2/8/2024 |
SWTX SpringWorks Therapeutics | $42.95 +3.7% | 2/5/2024 | Initiated by | Guggenheim | - | Buy | $75.00 | Low | View details for Guggenheim rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 2/5/2024 |
SN SharkNinja | 71.40 +1.4% | 2/5/2024 | Initiated by | Guggenheim | - | Buy | 60.00 | Low | View details for Guggenheim rating of SharkNinja (NYSE:SN) on 2/5/2024 |
APTV Aptiv | $82.84 +0.1% | 2/2/2024 | Target Lowered by | Guggenheim | - | Buy -> Buy | $120.00 -> $103.00 | Low | View details for Guggenheim rating of Aptiv (NYSE:APTV) on 2/2/2024 |
TSCO Tractor Supply | $274.50 +1.0% | 2/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $210.00 -> $255.00 | Low | View details for Guggenheim rating of Tractor Supply (NASDAQ:TSCO) on 2/2/2024 |
META Meta Platforms | $471.85 +0.8% | 2/2/2024 | Target Raised by | Guggenheim | - | Buy | $380.00 -> $520.00 | Low | View details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 2/2/2024 |
CMS CMS Energy | $62.39 -0.8% | 2/2/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $60.00 -> $64.00 | Low | View details for Guggenheim rating of CMS Energy (NYSE:CMS) on 2/2/2024 |
HCAT Health Catalyst | $6.84 +0.7% | 1/26/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $14.00 | Low | View details for Guggenheim rating of Health Catalyst (NASDAQ:HCAT) on 1/26/2024 |
OTLK Outlook Therapeutics | $7.40 -1.9% | 1/25/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $40.00 | Low | View details for Guggenheim rating of Outlook Therapeutics (NASDAQ:OTLK) on 1/25/2024 |
NFLX Netflix | $613.66 -0.5% | 1/24/2024 | Target Raised by | Guggenheim | - | Buy | $500.00 -> $600.00 | Low | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 1/24/2024 |
NEE NextEra Energy | $75.42 +1.1% | 1/22/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $70.00 -> $80.00 | Low | View details for Guggenheim rating of NextEra Energy (NYSE:NEE) on 1/22/2024 |
PEG Public Service Enterprise Group | $73.74 +0.3% | 1/22/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | $61.00 | Low | View details for Guggenheim rating of Public Service Enterprise Group (NYSE:PEG) on 1/22/2024 |
IDA IDACORP | $97.68 -0.4% | 1/22/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | $93.00 | Low | View details for Guggenheim rating of IDACORP (NYSE:IDA) on 1/22/2024 |
PNW Pinnacle West Capital | $77.00 +0.1% | 1/22/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $78.00 | Low | View details for Guggenheim rating of Pinnacle West Capital (NYSE:PNW) on 1/22/2024 |
NWE NorthWestern Energy Group | $51.47 -0.8% | 1/22/2024 | Upgraded by | Guggenheim | - | Sell -> Neutral | $47.00 | Low | View details for Guggenheim rating of NorthWestern Energy Group (NYSE:NWE) on 1/22/2024 |
EVRG Evergy | $55.30 -0.8% | 1/22/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | $52.00 | Low | View details for Guggenheim rating of Evergy (NYSE:EVRG) on 1/22/2024 |
DTE DTE Energy | $114.78 -0.5% | 1/22/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | $111.00 | Low | View details for Guggenheim rating of DTE Energy (NYSE:DTE) on 1/22/2024 |
AEP American Electric Power | $90.79 -0.8% | 1/22/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | $81.00 | Low | View details for Guggenheim rating of American Electric Power (NASDAQ:AEP) on 1/22/2024 |
ES Eversource Energy | $60.90 -0.6% | 1/22/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $60.00 -> $72.00 | Low | View details for Guggenheim rating of Eversource Energy (NYSE:ES) on 1/22/2024 |
EIX Edison International | $74.92 +0.6% | 1/22/2024 | Upgraded by | Guggenheim | - | Neutral -> Buy | $66.00 -> $84.00 | Low | View details for Guggenheim rating of Edison International (NYSE:EIX) on 1/22/2024 |
AVA Avista | $38.25 0.0% | 1/22/2024 | Upgraded by | Guggenheim | - | Sell -> Neutral | $34.00 | Low | View details for Guggenheim rating of Avista (NYSE:AVA) on 1/22/2024 |
ALE ALLETE | $62.93 -0.9% | 1/22/2024 | Upgraded by | Guggenheim | - | Sell -> Neutral | $58.00 | Low | View details for Guggenheim rating of ALLETE (NYSE:ALE) on 1/22/2024 |
NAMS NewAmsterdam Pharma | $20.50 +1.4% | 1/18/2024 | Initiated by | Guggenheim | - | Buy | $30.00 | Low | View details for Guggenheim rating of NewAmsterdam Pharma (NASDAQ:NAMS) on 1/18/2024 |
ALLO Allogene Therapeutics | $2.97 +2.4% | 1/5/2024 | Downgraded by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Allogene Therapeutics (NASDAQ:ALLO) on 1/5/2024 |
APGE Apogee Therapeutics | $53.99 +2.4% | 1/3/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $29.00 -> $44.00 | Low | View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 1/3/2024 |
HUGE BUY ALERT: Move Fast, Musk... (Ad) I recently traveled to Phoenix, Arizona...And based on what I saw out there, I'm prepared to put my reputation on the line.
Since 2018, my investment recommendations have averaged 115% per year.
But one investment I've just discovered could blow them all away. You won't believe what I saw in Phoenix. |
LBPH Longboard Pharmaceuticals | $20.35 +2.1% | 1/2/2024 | Target Raised by | Guggenheim | - | Buy -> Buy | $16.00 -> $32.00 | Low | View details for Guggenheim rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 1/2/2024 |
WW WW International | $2.08 +1.0% | 12/20/2023 | Initiated by | Guggenheim | - | Buy | $14.00 | Low | View details for Guggenheim rating of WW International (NASDAQ:WW) on 12/20/2023 |
SNAP Snap | $15.62 -0.9% | 12/18/2023 | Upgraded by | Guggenheim | - | Neutral -> Buy | $9.00 -> $23.00 | Low | View details for Guggenheim rating of Snap (NYSE:SNAP) on 12/18/2023 |
ETSY Etsy | $63.57 +1.7% | 12/15/2023 | Target Raised by | Guggenheim | - | Buy -> Buy | $75.00 -> $95.00 | Low | View details for Guggenheim rating of Etsy (NASDAQ:ETSY) on 12/15/2023 |
TSLA Tesla | $177.55 +3.3% | 12/15/2023 | Target Raised by | Guggenheim | - | Sell -> Sell | $125.00 -> $132.00 | Low | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 12/15/2023 |
EXC Exelon | $38.40 +0.7% | 12/15/2023 | Downgraded by | Guggenheim | - | Buy -> Neutral | $44.00 -> $40.00 | Low | View details for Guggenheim rating of Exelon (NASDAQ:EXC) on 12/15/2023 |
PACB Pacific Biosciences of California | $2.23 +15.5% | 12/14/2023 | Initiated by | Guggenheim | - | Neutral | | Low | View details for Guggenheim rating of Pacific Biosciences of California (NASDAQ:PACB) on 12/14/2023 |
NTRA Natera | $105.52 +2.1% | 12/14/2023 | Initiated by | Guggenheim | - | Buy | $70.00 | Low | View details for Guggenheim rating of Natera (NASDAQ:NTRA) on 12/14/2023 |
TXG 10x Genomics | $26.54 -1.6% | 12/14/2023 | Initiated by | Guggenheim | - | Buy | $60.00 | Low | View details for Guggenheim rating of 10x Genomics (NASDAQ:TXG) on 12/14/2023 |
MYGN Myriad Genetics | $25.36 +1.7% | 12/14/2023 | Initiated by | Guggenheim | - | Buy | $23.00 | Low | View details for Guggenheim rating of Myriad Genetics (NASDAQ:MYGN) on 12/14/2023 |
ILMN Illumina | $115.58 +2.5% | 12/14/2023 | Initiated by | Guggenheim | - | Buy | $155.00 | Low | View details for Guggenheim rating of Illumina (NASDAQ:ILMN) on 12/14/2023 |
GH Guardant Health | $24.73 +3.0% | 12/14/2023 | Initiated by | Guggenheim | - | Neutral | | Low | View details for Guggenheim rating of Guardant Health (NASDAQ:GH) on 12/14/2023 |
EXAS Exact Sciences | $54.00 -2.9% | 12/14/2023 | Initiated by | Guggenheim | - | Buy | $90.00 | Low | View details for Guggenheim rating of Exact Sciences (NASDAQ:EXAS) on 12/14/2023 |
CSTL Castle Biosciences | $23.91 -1.4% | 12/14/2023 | Initiated by | Guggenheim | - | Buy | $25.00 | Low | View details for Guggenheim rating of Castle Biosciences (NASDAQ:CSTL) on 12/14/2023 |
AKYA Akoya Biosciences | $2.90 -29.6% | 12/14/2023 | Initiated by | Guggenheim | - | Neutral | | Low | View details for Guggenheim rating of Akoya Biosciences (NASDAQ:AKYA) on 12/14/2023 |
SYRE Spyre Therapeutics | $39.29 +6.2% | 12/11/2023 | Initiated by | Guggenheim | - | Buy | $44.00 | Low | View details for Guggenheim rating of Spyre Therapeutics (NASDAQ:SYRE) on 12/11/2023 |
PSTG Pure Storage | $56.41 +3.8% | 12/7/2023 | Initiated by | Guggenheim | - | Buy | $48.00 | Low | View details for Guggenheim rating of Pure Storage (NYSE:PSTG) on 12/7/2023 |
NEE NextEra Energy | $75.42 +1.1% | 12/6/2023 | Target Raised by | Guggenheim | - | Buy -> Buy | $65.00 -> $70.00 | Low | View details for Guggenheim rating of NextEra Energy (NYSE:NEE) on 12/6/2023 |
NEP NextEra Energy Partners | $33.41 +6.6% | 12/6/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $42.00 -> $37.00 | Low | View details for Guggenheim rating of NextEra Energy Partners (NYSE:NEP) on 12/6/2023 |
SPHR Sphere Entertainment | $38.01 -1.4% | 12/6/2023 | Upgraded by | Guggenheim | - | Neutral -> Buy | $38.00 -> $40.00 | Low | View details for Guggenheim rating of Sphere Entertainment (NYSE:SPHR) on 12/6/2023 |
INCY Incyte | $57.05 -1.0% | 12/4/2023 | Upgraded by | Guggenheim | - | Neutral -> Buy | $86.00 | Low | View details for Guggenheim rating of Incyte (NASDAQ:INCY) on 12/4/2023 |
SLNO Soleno Therapeutics | $43.50 +1.6% | 11/21/2023 | Reiterated by | Guggenheim | - | Buy | $40.00 | Low | View details for Guggenheim rating of Soleno Therapeutics (NASDAQ:SLNO) on 11/21/2023 |
ARVN Arvinas | $31.35 -0.7% | 11/20/2023 | Upgraded by | Guggenheim | - | Neutral -> Buy | $40.00 | Low | View details for Guggenheim rating of Arvinas (NASDAQ:ARVN) on 11/20/2023 |
BWA BorgWarner | $37.59 -0.1% | 11/16/2023 | Upgraded by | Guggenheim | - | Neutral -> Buy | $41.00 | Low | View details for Guggenheim rating of BorgWarner (NYSE:BWA) on 11/16/2023 |
DKNG DraftKings | $44.13 +2.1% | 11/15/2023 | Target Raised by | Guggenheim | - | Buy -> Buy | $39.00 -> $45.00 | Low | View details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 11/15/2023 |
HD Home Depot | $340.50 -0.1% | 11/15/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $360.00 -> $340.00 | Low | View details for Guggenheim rating of Home Depot (NYSE:HD) on 11/15/2023 |
HLVX HilleVax | $13.13 -3.7% | 11/15/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $38.00 -> $34.00 | Low | View details for Guggenheim rating of HilleVax (NASDAQ:HLVX) on 11/15/2023 |
MLTX MoonLake Immunotherapeutics | $40.77 -2.3% | 11/15/2023 | Target Raised by | Guggenheim | - | Buy -> Buy | $70.00 -> $77.00 | Low | View details for Guggenheim rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 11/15/2023 |
ROIV Roivant Sciences | $11.33 +1.3% | 11/15/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $17.00 -> $16.00 | Low | View details for Guggenheim rating of Roivant Sciences (NASDAQ:ROIV) on 11/15/2023 |
XPOF Xponential Fitness | $8.87 -6.0% | 11/15/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $30.00 -> $25.00 | Low | View details for Guggenheim rating of Xponential Fitness (NYSE:XPOF) on 11/15/2023 |
ARRY Array Technologies | $12.64 -0.2% | 11/8/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $36.00 -> $30.00 | N/A | View details for Guggenheim rating of Array Technologies (NASDAQ:ARRY) on 11/8/2023 |
IDYA IDEAYA Biosciences | $41.80 +1.8% | 11/8/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $48.00 -> $44.00 | Low | View details for Guggenheim rating of IDEAYA Biosciences (NASDAQ:IDYA) on 11/8/2023 |
TKO TKO Group | $102.24 +2.9% | 11/8/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $126.00 -> $120.00 | Low | View details for Guggenheim rating of TKO Group (NYSE:TKO) on 11/8/2023 |
XNCR Xencor | $20.33 -4.7% | 11/8/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $40.00 -> $34.00 | Low | View details for Guggenheim rating of Xencor (NASDAQ:XNCR) on 11/8/2023 |
MGNX MacroGenics | $4.45 +1.6% | 11/7/2023 | Upgraded by | Guggenheim | - | Neutral -> Buy | $12.00 | Low | View details for Guggenheim rating of MacroGenics (NASDAQ:MGNX) on 11/7/2023 |
SVRA Savara | $4.81 +4.8% | 11/7/2023 | Initiated by | Guggenheim | - | Buy | $7.00 | Low | View details for Guggenheim rating of Savara (NASDAQ:SVRA) on 11/7/2023 |
UTL Unitil | $53.98 +0.1% | 11/6/2023 | Initiated by | Guggenheim | - | Neutral | | Low | View details for Guggenheim rating of Unitil (NYSE:UTL) on 11/6/2023 |
DTE DTE Energy | $114.78 -0.5% | 11/3/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $110.00 -> $103.00 | Low | View details for Guggenheim rating of DTE Energy (NYSE:DTE) on 11/3/2023 |
EIX Edison International | $74.92 +0.6% | 11/3/2023 | Target Raised by | Guggenheim | - | Neutral -> Neutral | $63.00 -> $66.00 | Low | View details for Guggenheim rating of Edison International (NYSE:EIX) on 11/3/2023 |
ETR Entergy | $111.30 -0.5% | 11/3/2023 | Target Raised by | Guggenheim | - | Buy -> Buy | $99.00 -> $103.00 | Low | View details for Guggenheim rating of Entergy (NYSE:ETR) on 11/3/2023 |
ETSY Etsy | $63.57 +1.7% | 11/3/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $80.00 -> $75.00 | Low | View details for Guggenheim rating of Etsy (NASDAQ:ETSY) on 11/3/2023 |
IQV IQVIA | $231.14 +0.9% | 11/3/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $253.00 -> $220.00 | Low | View details for Guggenheim rating of IQVIA (NYSE:IQV) on 11/3/2023 |
SBGI Sinclair | $15.55 +3.5% | 11/3/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $30.00 -> $20.00 | Low | View details for Guggenheim rating of Sinclair (NASDAQ:SBGI) on 11/3/2023 |
W Wayfair | $71.28 -0.1% | 11/3/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $100.00 -> $65.00 | Low | View details for Guggenheim rating of Wayfair (NYSE:W) on 11/3/2023 |
STEM Stem | $1.37 +13.2% | 11/3/2023 | Downgraded by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of Stem (NYSE:STEM) on 11/3/2023 |
GNRC Generac | $143.08 +2.1% | 11/3/2023 | Upgraded by | Guggenheim | - | Neutral -> Buy | $142.00 | Low | View details for Guggenheim rating of Generac (NYSE:GNRC) on 11/3/2023 |
CFLT Confluent | $30.67 +2.4% | 11/3/2023 | Upgraded by | Guggenheim | - | Neutral -> Buy | $23.00 | Low | View details for Guggenheim rating of Confluent (NASDAQ:CFLT) on 11/3/2023 |
SEDG SolarEdge Technologies | $53.75 +2.9% | 11/2/2023 | Downgraded by | Guggenheim | - | Buy -> Neutral | | Low | View details for Guggenheim rating of SolarEdge Technologies (NASDAQ:SEDG) on 11/2/2023 |
NRG NRG Energy | $82.08 -0.5% | 11/1/2023 | Upgraded by | Guggenheim | - | Neutral -> Buy | $50.00 | Low | View details for Guggenheim rating of NRG Energy (NYSE:NRG) on 11/1/2023 |
TRML Tourmaline Bio | $14.41 -0.2% | 10/31/2023 | Initiated by | Guggenheim | - | Buy | $50.00 | Low | View details for Guggenheim rating of Tourmaline Bio (NASDAQ:TRML) on 10/31/2023 |
Revolutionizing the Green Energy Space and Building Shareholder Value Along the Way (Ad) As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closely! Learn how this American company is leading the lithium-ion revolution |
DNTH Dianthus Therapeutics | $27.94 +7.4% | 10/30/2023 | Initiated by | Guggenheim | - | Buy | $45.00 | Low | View details for Guggenheim rating of Dianthus Therapeutics (NASDAQ:DNTH) on 10/30/2023 |
IDA IDACORP | $97.68 -0.4% | 10/27/2023 | Initiated by | Guggenheim | - | Buy | $104.00 | Low | View details for Guggenheim rating of IDACORP (NYSE:IDA) on 10/27/2023 |
LYV Live Nation Entertainment | $95.83 +0.3% | 10/26/2023 | Target Raised by | Guggenheim | - | Buy -> Buy | $124.00 -> $125.00 | Low | View details for Guggenheim rating of Live Nation Entertainment (NYSE:LYV) on 10/26/2023 |
AKAM Akamai Technologies | $93.15 -1.2% | 10/26/2023 | Upgraded by | Guggenheim | - | Sell -> Neutral | | Low | View details for Guggenheim rating of Akamai Technologies (NASDAQ:AKAM) on 10/26/2023 |
FND Floor & Decor | $123.55 +0.8% | 10/23/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $115.00 -> $95.00 | Low | View details for Guggenheim rating of Floor & Decor (NYSE:FND) on 10/23/2023 |
DT Dynatrace | $46.43 +1.1% | 10/23/2023 | Initiated by | Guggenheim | - | Buy | $58.00 | Low | View details for Guggenheim rating of Dynatrace (NYSE:DT) on 10/23/2023 |
DDOG Datadog | $116.75 -1.3% | 10/23/2023 | Initiated by | Guggenheim | - | Neutral | | Low | View details for Guggenheim rating of Datadog (NASDAQ:DDOG) on 10/23/2023 |
MCD McDonald's | $270.66 -0.2% | 10/19/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $330.00 -> $285.00 | Low | View details for Guggenheim rating of McDonald’s (NYSE:MCD) on 10/19/2023 |
ANIP ANI Pharmaceuticals | $66.21 -1.7% | 10/19/2023 | Reiterated by | Guggenheim | - | Buy -> Buy | $72.00 | Low | View details for Guggenheim rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 10/19/2023 |
NFLX Netflix | $613.66 -0.5% | 10/19/2023 | Reiterated by | Guggenheim | - | Buy -> Buy | $460.00 | Low | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 10/19/2023 |
TSLA Tesla | $177.55 +3.3% | 10/19/2023 | Reiterated by | Guggenheim | - | Sell -> Sell | $125.00 | Low | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 10/19/2023 |
NOW ServiceNow | $721.62 -1.2% | 10/19/2023 | Reiterated by | Guggenheim | - | Buy -> Buy | $657.00 | Low | View details for Guggenheim rating of ServiceNow (NYSE:NOW) on 10/19/2023 |
ROIV Roivant Sciences | $11.33 +1.3% | 10/17/2023 | Initiated by | Guggenheim | - | Buy | $17.00 | Low | View details for Guggenheim rating of Roivant Sciences (NASDAQ:ROIV) on 10/17/2023 |
ES Eversource Energy | $60.90 -0.6% | 10/13/2023 | Downgraded by | Guggenheim | - | Buy -> Neutral | $60.00 | Low | View details for Guggenheim rating of Eversource Energy (NYSE:ES) on 10/13/2023 |
EXEL Exelixis | $20.99 -1.3% | 10/11/2023 | Reiterated by | Guggenheim | - | Buy -> Buy | $30.00 | Low | View details for Guggenheim rating of Exelixis (NASDAQ:EXEL) on 10/11/2023 |
DIS Walt Disney | $105.33 -0.5% | 10/10/2023 | Target Lowered by | Guggenheim | - | | $125.00 -> $115.00 | Low | View details for Guggenheim rating of Walt Disney (NYSE:DIS) on 10/10/2023 |
NMRA Neumora Therapeutics | $9.58 +6.9% | 10/10/2023 | Initiated by | Guggenheim | - | Buy | $22.00 | Low | View details for Guggenheim rating of Neumora Therapeutics (NASDAQ:NMRA) on 10/10/2023 |
WEC WEC Energy Group | $84.42 -0.5% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $94.00 -> $84.00 | Low | View details for Guggenheim rating of WEC Energy Group (NYSE:WEC) on 10/9/2023 |
SRE Sempra | $76.63 -0.6% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $86.00 -> $76.00 | Low | View details for Guggenheim rating of Sempra (NYSE:SRE) on 10/9/2023 |
SR Spire | $61.85 -0.6% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $65.00 -> $55.00 | Low | View details for Guggenheim rating of Spire (NYSE:SR) on 10/9/2023 |
SO Southern | $78.71 +0.0% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $80.00 -> $72.00 | Low | View details for Guggenheim rating of Southern (NYSE:SO) on 10/9/2023 |
PPL PPL | $29.19 +0.1% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $31.00 -> $27.00 | Low | View details for Guggenheim rating of PPL (NYSE:PPL) on 10/9/2023 |
POR Portland General Electric | $44.28 -1.1% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $48.00 -> $45.00 | Low | View details for Guggenheim rating of Portland General Electric (NYSE:POR) on 10/9/2023 |
PNW Pinnacle West Capital | $77.00 +0.1% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $83.00 -> $73.00 | Low | View details for Guggenheim rating of Pinnacle West Capital (NYSE:PNW) on 10/9/2023 |
PEG Public Service Enterprise Group | $73.74 +0.3% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $70.00 -> $64.00 | Low | View details for Guggenheim rating of Public Service Enterprise Group (NYSE:PEG) on 10/9/2023 |
PCG PG&E | $18.01 +0.8% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $21.00 -> $19.00 | Low | View details for Guggenheim rating of PG&E (NYSE:PCG) on 10/9/2023 |
OGS ONE Gas | $63.95 +0.2% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $73.00 -> $64.00 | Low | View details for Guggenheim rating of ONE Gas (NYSE:OGS) on 10/9/2023 |
OGE OGE Energy | $36.37 +0.2% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $36.00 -> $32.00 | Low | View details for Guggenheim rating of OGE Energy (NYSE:OGE) on 10/9/2023 |
NWN Northwest Natural | $37.99 -1.3% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $42.00 -> $37.00 | Low | View details for Guggenheim rating of Northwest Natural (NYSE:NWN) on 10/9/2023 |
NWE NorthWestern Energy Group | $51.47 -0.8% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $48.00 -> $41.00 | Low | View details for Guggenheim rating of NorthWestern Energy Group (NYSE:NWE) on 10/9/2023 |
NJR New Jersey Resources | $43.97 -0.3% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $47.00 -> $42.00 | Low | View details for Guggenheim rating of New Jersey Resources (NYSE:NJR) on 10/9/2023 |
NI NiSource | $28.87 +0.2% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $30.00 -> $27.00 | Low | View details for Guggenheim rating of NiSource (NYSE:NI) on 10/9/2023 |
NEE NextEra Energy | $75.42 +1.1% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $73.00 -> $65.00 | Low | View details for Guggenheim rating of NextEra Energy (NYSE:NEE) on 10/9/2023 |
LNT Alliant Energy | $51.36 +0.0% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $49.00 -> $43.00 | Low | View details for Guggenheim rating of Alliant Energy (NASDAQ:LNT) on 10/9/2023 |
FE FirstEnergy | $39.84 +0.4% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $44.00 -> $38.00 | Low | View details for Guggenheim rating of FirstEnergy (NYSE:FE) on 10/9/2023 |
EXC Exelon | $38.40 +0.7% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $45.00 -> $41.00 | Low | View details for Guggenheim rating of Exelon (NASDAQ:EXC) on 10/9/2023 |
EVRG Evergy | $55.30 -0.8% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $62.00 -> $54.00 | Low | View details for Guggenheim rating of Evergy (NYSE:EVRG) on 10/9/2023 |
ETR Entergy | $111.30 -0.5% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $113.00 -> $99.00 | Low | View details for Guggenheim rating of Entergy (NYSE:ETR) on 10/9/2023 |
ES Eversource Energy | $60.90 -0.6% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $80.00 -> $70.00 | Low | View details for Guggenheim rating of Eversource Energy (NYSE:ES) on 10/9/2023 |
EIX Edison International | $74.92 +0.6% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $74.00 -> $63.00 | Low | View details for Guggenheim rating of Edison International (NYSE:EIX) on 10/9/2023 |
ED Consolidated Edison | $96.64 -1.0% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $85.00 -> $82.00 | Low | View details for Guggenheim rating of Consolidated Edison (NYSE:ED) on 10/9/2023 |
DUK Duke Energy | $102.31 -0.6% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $102.00 -> $93.00 | Low | View details for Guggenheim rating of Duke Energy (NYSE:DUK) on 10/9/2023 |
DTE DTE Energy | $114.78 -0.5% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $124.00 -> $110.00 | Low | View details for Guggenheim rating of DTE Energy (NYSE:DTE) on 10/9/2023 |
D Dominion Energy | $52.84 -0.4% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $56.00 -> $49.00 | Low | View details for Guggenheim rating of Dominion Energy (NYSE:D) on 10/9/2023 |
CPK Chesapeake Utilities | $110.75 +0.3% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $112.00 -> $99.00 | Low | View details for Guggenheim rating of Chesapeake Utilities (NYSE:CPK) on 10/9/2023 |
CNP CenterPoint Energy | $29.68 +0.1% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $34.00 -> $29.00 | Low | View details for Guggenheim rating of CenterPoint Energy (NYSE:CNP) on 10/9/2023 |
CMS CMS Energy | $62.39 -0.8% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $61.00 -> $54.00 | Low | View details for Guggenheim rating of CMS Energy (NYSE:CMS) on 10/9/2023 |
AWK American Water Works | $133.13 -0.5% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $147.00 -> $126.00 | Low | View details for Guggenheim rating of American Water Works (NYSE:AWK) on 10/9/2023 |
AVA Avista | $38.25 0.0% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $33.00 -> $26.00 | Low | View details for Guggenheim rating of Avista (NYSE:AVA) on 10/9/2023 |
ALE ALLETE | $62.93 -0.9% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $49.00 -> $41.00 | Low | View details for Guggenheim rating of ALLETE (NYSE:ALE) on 10/9/2023 |
AEP American Electric Power | $90.79 -0.8% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $96.00 -> $85.00 | Low | View details for Guggenheim rating of American Electric Power (NASDAQ:AEP) on 10/9/2023 |
AEE Ameren | $74.88 +0.6% | 10/9/2023 | Target Lowered by | Guggenheim | - | | $85.00 -> $75.00 | Low | View details for Guggenheim rating of Ameren (NYSE:AEE) on 10/9/2023 |
ARM ARM | 116.65 -0.5% | 10/9/2023 | Initiated by | Guggenheim | - | Buy | 64.00 | Low | View details for Guggenheim rating of ARM (NASDAQ:ARM) on 10/9/2023 |
WBD Warner Bros. Discovery | $8.56 +2.1% | 10/4/2023 | Target Lowered by | Guggenheim | - | | $18.00 -> $15.00 | Low | View details for Guggenheim rating of Warner Bros. Discovery (NASDAQ:WBD) on 10/4/2023 |
DKNG DraftKings | $44.13 +2.1% | 10/4/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $38.00 -> $37.00 | Low | View details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 10/4/2023 |
SNDX Syndax Pharmaceuticals | $21.66 +3.3% | 10/3/2023 | Target Raised by | Guggenheim | - | | $42.00 -> $43.00 | Low | View details for Guggenheim rating of Syndax Pharmaceuticals (NASDAQ:SNDX) on 10/3/2023 |
EVRG Evergy | $55.30 -0.8% | 10/3/2023 | Target Lowered by | Guggenheim | - | | $68.00 -> $62.00 | Low | View details for Guggenheim rating of Evergy (NYSE:EVRG) on 10/3/2023 |
PARA Paramount Global | $12.33 -5.2% | 10/2/2023 | Target Lowered by | Guggenheim | - | Buy -> Buy | $21.00 -> $19.00 | Low | View details for Guggenheim rating of Paramount Global (NASDAQ:PARA) on 10/2/2023 |
GPCR Structure Therapeutics | $35.70 -0.8% | 10/2/2023 | Target Raised by | Guggenheim | - | | $50.00 -> $92.00 | Low | View details for Guggenheim rating of Structure Therapeutics (NASDAQ:GPCR) on 10/2/2023 |
META Meta Platforms | $471.85 +0.8% | 9/27/2023 | Target Raised by | Guggenheim | - | Buy -> Buy | $375.00 -> $380.00 | Low | View details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 9/27/2023 |